Blog

Vivek Subbiah: Zhen, is that pin in your suit for Disney 100?

Photo taken from Vivek Subbiah/LinkedIn

Nov 9, 2023, 18:04

Vivek Subbiah: Zhen, is that pin in your suit for Disney 100?

Vivek Subbiah, Chief of Early-Phase Drug Development at

“True conversation with Zhen Su and the Society for Immunotherapy of Cancer (SITC23):

Me: Zhen, is that pin in your suit for Disney 100?
Zhen was confused.
Me: Disney? 100-year anniversary of Walt Disney.
Zhen: 100 = Goal is accelerating 100 FDA-Approved immunotherapy drugs over the next 10 years by the new biotech/SITC committee.

Such a great discussion with the terrific Zhen, Marcy Vallone with the Sarah Cannon Research Institute. This is the reason why we need face to face meetings that we missed with the virtual meetings in the pandemic. Kudos on forming the new initiative biotech multi-stakeholder Committee chaired by Zhen Su and Kristen Hege.”

Source: Vivek Subbiah/LinkedIn

cancer Disney FDA Kristen Hege Marcy Vallone OncoDaily Oncology Sarah Cannon Research Institute SITC23 Society for Immunotherapy of Cancer Vivek Subbiah Walt Disney Zhen Su

Esophageal Cancer: Symptoms, Causes, Stages, Diagnosis & Treatment

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Special Coverage